Blueprint Medicines Corp - Company Profile

Powered by

All the data and insights you need on Blueprint Medicines Corp in one report.

  • Save hours of research time and resources with
    our up-to-date Blueprint Medicines Corp Strategy Report

  • Understand Blueprint Medicines Corp position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Blueprint Medicines Corp: Executives

The following section provides information on Blueprint Medicines Corp’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Blueprint Medicines Corp's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

Jeffrey W. Albers

Chairman Executive Board Since: 2022 Age: 51

Kate Haviland

Chief Executive Officer; Director; President Executive Board Since: 2022 Age: 47

Mike Landsittel

Chief Financial Officer Senior Management Since: 2019 Age: 51

Christina Rossi

Chief Operating Officer Senior Management Since: 2022 Age: 47

Debra Durso-Bumpus

Chief People Officer Senior Management Since: 2020 Age: 53
Gain a 360-degree view of Blueprint Medicines Corp and make more informed decisions for your business Gain a 360-degree view of Blueprint Medicines Corp and make more informed decisions for your business Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Start of HubSpot Embed Code End of HubSpot Embed Code